<SEC-DOCUMENT>0001654954-24-011975.txt : 20240917
<SEC-HEADER>0001654954-24-011975.hdr.sgml : 20240917
<ACCEPTANCE-DATETIME>20240916174519
ACCESSION NUMBER:		0001654954-24-011975
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240916
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240917
DATE AS OF CHANGE:		20240916

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11889
		FILM NUMBER:		241302091

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cvm_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:cvm="http://cvm.com/20240916"><head><title>cvm_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2024-09-16to2024-09-16" id="ixv-282">0000725363</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2024-09-16to2024-09-16" format="ixt:booleanfalse" id="ixv-283">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cvm-20240916.xsd"/></ix:references><ix:resources><xbrli:context id="From2024-09-16to2024-09-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000725363</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-16</xbrli:startDate><xbrli:endDate>2024-09-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>WASHINGTON, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2024-09-16to2024-09-16" id="ixv-303">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">CURRENT REPORT</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Pursuant to Section 13 or 15(d) of the</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Securities Exchange Act of 1934</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Date of Report (date of earliest event reported):&#160;&#160;<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2024-09-16to2024-09-16" format="ixt:datemonthdayyearen" id="ixv-304">September 16, 2024</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:left;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2024-09-16to2024-09-16" id="ixv-305">CEL-SCI CORPORATION</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of Registrant as specified in its charter)</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:left;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:32%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2024-09-16to2024-09-16" format="ixt-sec:stateprovnameen" id="ixv-306">Colorado</ix:nonNumeric></p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:32%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="From2024-09-16to2024-09-16" id="ixv-307">001-11889</ix:nonNumeric></p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:32%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2024-09-16to2024-09-16" id="ixv-308">84-0916344</ix:nonNumeric></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or other jurisdiction </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">of incorporation)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission File No.)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(IRS Employer</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Identification No.)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2024-09-16to2024-09-16" id="ixv-309">8229 Boone Blvd</ix:nonNumeric>. <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="From2024-09-16to2024-09-16" id="ixv-310">#802</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2024-09-16to2024-09-16" id="ixv-311">Vienna</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2024-09-16to2024-09-16" id="ixv-312">VA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2024-09-16to2024-09-16" id="ixv-313">22182</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of principal executive offices, including Zip Code)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Registrant&#8217;s telephone number, including area code:&#160;&#160; <span style="text-decoration:underline">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="From2024-09-16to2024-09-16" id="ixv-314">703</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2024-09-16to2024-09-16" id="ixv-315">506-9460</ix:nonNumeric></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">N/A</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former name or former address if changed since last report)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="From2024-09-16to2024-09-16" format="ixt-sec:boolballotbox" id="ixv-316">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="From2024-09-16to2024-09-16" format="ixt-sec:boolballotbox" id="ixv-317">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="From2024-09-16to2024-09-16" format="ixt-sec:boolballotbox" id="ixv-318">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b) </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="From2024-09-16to2024-09-16" format="ixt-sec:boolballotbox" id="ixv-319">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14c)) </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:32%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Title of Each Class</p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:32%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Trading Symbol(s)</p></td><td style="width:2%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:32%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Name of Each Exchange on Which Registered</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="From2024-09-16to2024-09-16" id="ixv-320">Common Stock</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="From2024-09-16to2024-09-16" id="ixv-321">CVM</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="From2024-09-16to2024-09-16" format="ixt-sec:exchnameen" id="ixv-322">NYSE</ix:nonNumeric> American</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;203.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;204.12b-2 of this chapter.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2024-09-16to2024-09-16" format="ixt-sec:boolballotbox" id="ixv-323">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 8.01. Other Events.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 16, 2024, CEL-SCI Corporation (the &#8220;Company&#8221;) issued a press release reporting new data from its concluded Phase 3 study of Multikine&#174; (Leukocyte Interleukin, Injection) were presented at the European Society for Medical Oncology (ESMO) 2024 Congress on Saturday, September 14, 2024 in a poster titled &#8220;Prognostic significance of diagnostic staging in treatment na&#239;ve, resectable locally advanced primary oral cavity squamous cell carcinoma for neoadjuvant Leukocyte Interleukin Injection immunotherapy&#8221;.&#160; This data is highly relevant to the Company&#8217;s 212 patient confirmatory Registration Study which has received the U.S. Food and Drug Administration&#8217;s (FDA) go-ahead and is currently under preparation. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item&#160;9.01 Financial Statements and Exhibits.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:7%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exhibit&#160;No.</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Description</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><a href="cvm_ex99.htm">99</a></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><a href="cvm_ex99.htm">Press Release re. ESMO 2024 poster results </a></p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date:&#160;&#160;September 16, 2024</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>CEL-SCI CORPORATION</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:3%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:35%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:12%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">By:</p></td><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">/s/ Patricia Prichep</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Patricia B. Prichep</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Senior Vice President of Operations</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>cvm_ex99.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>cvm_ex99.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99</strong></p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-BOTTOM: #000000 1px solid;width:45%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="cvm_ex991img5.jpg"></p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:10%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:45%;"> <p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px"><img src="cvm_ex991img7.jpg"></p></td></tr> <tr style="height:15px"> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">8229 Boone Boulevard, Suite 802<strong><em> </em></strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Vienna, VA&nbsp;&nbsp;22182.&nbsp;USA</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Telephone (703) 506-9460&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">www.cel-sci.com&nbsp;&nbsp;&nbsp; </p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:bottom;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">COMPANY CONTACT:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">Gavin de Windt</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">CEL-SCI Corporation</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">(703) 506-9460</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&nbsp;&nbsp;</strong><strong>CEL-SCI&#8217;s Multikine&#174; Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head &amp; Neck Cancer Patients Who Were Deemed to be in the Treatment Group for Surgery and Radiation</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;text-align:justify;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"><strong><em>5-year survival rate of 82.6% and 73% reduction in overall risk of death (hazard ratio of 0.27) are the strongest Multikine efficacy results reported to date, reflecting results in patients who met the CEL-SCI confirmatory Registration Study target population criteria and were deemed at low risk for recurrence, therefore not recommended per NCCN guidelines to receive chemotherapy post-surgery </em></strong></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"><strong><em>Data provide further evidence that the selection criteria for CEL-SCI&#8217;s upcoming confirmatory Registration Study may yield improved clinical outcomes</em></strong></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"><strong><em>Future advances in diagnostic technologies that improve patient selection, such as PET scans (which will be used in the confirmatory study), may further optimize patient selection and Multikine&#8217;s already strong efficacy results from the current 5-year Overall Survival at 73% up into the 82% range</em></strong></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;"><strong><em>Clear unmet need: the 5-year survival rate remains below 50% in locally advanced resectable head and neck cancer patients who receive standard of care only </em></strong></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Vienna, VA, September 16, 2024 - </strong><u>CEL-SCI Corporation</u> <strong>(NYSE American: CVM) </strong>today reported new data from its concluded Phase 3 study of Multikine&#174; (Leukocyte Interleukin, Injection)* that were presented at the European Society for Medical Oncology (ESMO) 2024 Congress on Saturday, September 14, 2024 in a poster titled &#8220;Prognostic significance of diagnostic staging in treatment na&#239;ve, resectable locally advanced primary oral cavity squamous cell carcinoma for neoadjuvant Leukocyte Interleukin Injection immunotherapy&#8221;. This data is highly relevant to CEL-SCI&#8217;s 212 patient confirmatory Registration Study which has received the U.S. Food and Drug Administration&#8217;s (FDA) go-ahead and is currently under preparation.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Summary of Phase 3 Study: Multikine-treated patients who were recommended treatment of surgery and radiotherapy had a nearly 4-year survival benefit over control group&nbsp;&nbsp;&nbsp;</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As previously reported, CEL-SCI&#8217;s completed Phase 3 study of 923 patients showed that newly diagnosed head and neck cancer patients who were deemed at low risk for recurrence after surgery (and therefore recommended to receive only radiotherapy after surgery) had a median overall survival (OS) benefit of 46.5-months, almost 4-years, over control patients. However, patients who were deemed to be high risk for recurrence after surgery (and therefore recommended to have chemotherapy added to the radiotherapy after surgery) showed no survival benefit. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Upcoming FDA Confirmatory Registration Study</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Since the completed Phase 3 study showed clear survival benefit for some, but not all of the patients, the FDA requested that CEL-SCI conduct a confirmatory Registration Study focusing on the patients who showed the best survival benefit. Based on the data, CEL-SCI determined this target population to be patients with newly diagnosed locally advanced primary head and neck cancer with no lymph node involvement and with low PD-L1 tumor expression. Applying these selection criteria to the completed Phase 3 study of 923 patients resulted in the target population (n=114) having a 73% survival at 5 years vs a 45% survival at 5 years for the control patients, log rank p=0.0015. The hazard ratio was an exceptional 0.34, with a 95% confidence interval upper limit of 0.65; Wald p=0.0012 and achieving a 66% reduction in the overall risk of death. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Summary of New Data Presented at ESMO</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The new data presented at ESMO includes a further analysis of the 114 patients in the completed Phase 3 study who met these target population selection criteria and form the basis for the confirmatory study.&nbsp; Specifically, the new analysis focused on those patients who were deemed low risk for recurrence (recommended to be given only radiotherapy &#8211; but <u>no chemotherapy</u>, per National Comprehensive Cancer Network &#8220;NCCN&#8221; guidelines) following surgery (n=79) as opposed to the selected patients who were deemed high risk for recurrence and who were recommended to have chemotherapy added to their treatment following surgery per the same guidelines (n=35). </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">While the overall survival benefit was clear and statistically significant (log rank p=0.0015) for the entire target population (n=114), the 79 patients who were recommended to receive only radiotherapy benefited to an even greater degree from pre-surgery treatment with Multikine than the group of 114 as a whole. This target low risk population (n=38) had a 5-year overall survival of 82.6% when treated with Multikine vs. 47.3% when treated with standard of care alone (n=41), without overlap in their respective 95% confidence intervals. More recent analysis for the target low risk population (n=79) showed a hazard ratio of 0.27 (95% CI [0.12, 0.64], Wald p=0.0027) achieving a 73% reduction in overall risk of death.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Management Commentary</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#8220;The additional data presented this weekend at ESMO 2024 provides further evidence that we have identified the target population that has the greatest survival benefit from Multikine, and that our study criteria can select for these patients upon diagnosis, before surgery,&#8221; stated CEL-SCI CEO Geert Kersten. &#8220;It makes sense that Multikine, an immunotherapy, provides even greater benefit to patients who are not scheduled to receive chemotherapy following surgery, given the known detriments of chemotherapy on the immune system. Seeing more clearly than ever that patients who were not recommended chemotherapy benefited the most begs the question: What if, through better diagnostic technology such as the PET scan, which we will be using in the confirmatory study, resulting in better patient selection, we could treat only those patients who are&nbsp;supposed to be treated with radiotherapy alone, and <u>not</u> chemotherapy? The data presented at ESMO is clear. This would lead to even better 5-year survival, 82% instead of 73%.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">CEL-SCI&#8217;s CSO Eyal Talor, Ph.D. commented, &#8220;The criteria we developed for selecting these locally advanced head and neck cancer patients clearly showed that when patients were treated with Multikine before surgery, they demonstrated an overall survival advantage over control irrespective of whether these patients were characterized as being at low- or high-risk for recurrence following surgery. With this new analysis we also saw that patients selected by these criteria who are deemed low risk for recurrence post-surgery have a further improved survival outcome with a hazard ratio of 0.27, which even is better than the already exceptional hazard ratio of 0.34 seen for the overall selected population.&#8221; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="cvm_ex991img4.jpg"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Caption:</strong> CEL-SCI&#8217;s Multikine&#174; Increases Head and Neck Cancer 5-Year Survival Rate to 82.6%. The graph on the right side (n=79) demonstrates that the target low risk population had a 5-year survival rate of 82.6% when treated with Multikine (n=38) vs. 47.3% when treated with standard of care alone (n=41).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The data were presented at ESMO 2024 by the study&#8217;s co-author J&#243;zsef T&#237;m&#225;r MD, PhD, DSc, Professor Department of Pathology, Forensic and Insurance Medicine at Semmelweis University in Budapest, Hungary. Dr. Timar served as the Director of the Central Pathology Laboratory for CEL-SCI&#8217;s IT-MATTERS Phase 3 study. With 174 peer reviewed studies published, Dr. Timar is a founding editor, editor in chief, or a member of the editorial board of four oncology journals. He is the recipient of a dozen honors and awards for excellence in cancer research and teaching.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>About CEL-SCI Corporation</strong> </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">CEL-SCI believes that boosting a patient&#8217;s immune system while it is still intact should provide the greatest possible impact on survival. Multikine is designed to help the immune system "target" the tumor at a time when the immune system is still relatively intact and thereby thought to be better able to mount an attack on the tumor. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Multikine (Leukocyte Interleukin, Injection), a true first-line cancer therapy, has been dosed in over 740 patients and received Orphan Drug designation from the FDA for neoadjuvant therapy in patients with squamous cell carcinoma (cancer) of the head and neck. Based on the very strong data from the completed randomized controlled Phase 3 study, the FDA agreed to CEL-SCI&#8217;s target patient selection criteria and gave the go-ahead to conduct a small, focused, confirmatory Registration Study which will enroll 212 patients. CEL-SCI will enroll newly diagnosed locally advanced primary head and neck cancer patients with no lymph node involvement (determined via PET scan) and with low PD-L1 tumor expression (determined via biopsy), representing over 100,000 patients annually.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has operations in Vienna, Virginia, and near/in Baltimore, Maryland.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Forward-Looking Statements</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this press release, the words "intends," "believes," "anticipated," "plans" and "expects," and similar expressions, are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could cause or contribute to such differences include an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be shown to be safe and effective, receiving necessary regulatory approvals, difficulties in manufacturing any of the Company's potential products, inability to raise the necessary capital and the risk factors set forth from time to time in CEL-SCI's filings with the Securities and Exchange Commission, including but not limited to its report on Form 10-K for the year ended September 30, 2023. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>* Multikine (Leukocyte Interleukin, Injection) is the trademark that CEL-SCI has registered for this investigational therapy. This proprietary name is subject to FDA review in connection with the Company's future anticipated regulatory submission for approval. Multikine has not been licensed or approved for sale, barter or exchange by the FDA or any other regulatory agency. Similarly, its safety or efficacy has not been established for any use.</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cvm-20240916.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:cvm="http://cvm.com/20240916" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cvm.com/20240916">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://cvm.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="cvm-20240916_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cvm-20240916_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cvm-20240916_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cvm-20240916_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
 <import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
 <import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
 <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
 <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
 <import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
 <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
 <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
 <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cvm-20240916_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>cvm-20240916_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://cvm.com/role/Cover" xlink:href="cvm-20240916.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://cvm.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cvm-20240916_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cvm.com/role/Cover" xlink:href="cvm-20240916.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://cvm.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>cvm-20240916_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 09/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://cvm.com/role/Cover" xlink:href="cvm-20240916.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://cvm.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>cvm_ex991img7.jpg
<TEXT>
begin 644 cvm_ex991img7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  K 3 # 2(  A$! Q$!_\0
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MRD[<GG!7*^W'IBN#^%_AO1O$6@ZS;ZK8QS-YB*DVW]Y'E3RK=1_*O2/#*_\
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&6:* /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>cvm_ex991img5.jpg
<TEXT>
begin 644 cvm_ex991img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !7 -<# 2(  A$! Q$!_\0
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M( 88X8\\T >Q^!=>F\3>"=.UBY55N95*S!!A=ZL5)'UQG\:\R_: _P!?X?\
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MT0T];A))WW;9?W@.TXP.%7@<#TYJKX?O+B:ZLQ875Y>!K,M>_:]^U9=J%.6
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2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>cvm_ex991img4.jpg
<TEXT>
begin 644 cvm_ex991img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" $3 H,# 2(  A$! Q$!_\0
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M^TXW@70_B%JOA33X_#J:EBR <-()BA^4D=0PY_V16O\ \*3^)/\ T<-XF_\
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M8^!>K>*-)UB\0V-@^H:?>:7J$D"N2ORMF-@'7!S@Y%>>^)O"_BN;XA:3X/\
M ^J:NLD?AU+V*ZNO$5S']AE>Y;-PX.XW&.GEMQCCI0!U7_"D_B1_T<-XF_\
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M<4ZW^)@>>&TN--CCN)I(HH@;C:)PTDP:5,J/W8C@,@8X^\ <=:+ >E%5*E2
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MBMX8%"PQK& H7Y1C@# 'X"I!%&H.V-0"VX@#J?7ZUPES\2-/\M_[/T^YN;M
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M$N^2)7;"IC) /]V@#D&NM%:5I#\.=7+N58G[!'U48'\?'!(J0:IIJV$.G_\
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M_P"C37JU '$SZQ:W,MS)/X*UZ1[B#[+*3;+\\7S?+_K.GS-^=9C)H;7:7;>
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M6T)6Y3RY2)V!8;=O'R\<5L44 <%)X#LYFN))OM$ES/*LS3&_<,&'IA,*#@<
M=AZ4Q? .GM="1EG+1D'F\;:W(/(V8/W1VX^O->@5"O\ K)/P_B_IVH 9;1R1
MP!9-N\LS';TR23_6K-%% !1110 4444 %5K[_D'W7_7)OY&K-03Q>=;2P[MO
MF*5R.V1B@"!X[$N3)(H?OF4CG\Z3R]._YZ+_ -_3_C2?8[H];J,GU-N/\:/L
M=S_S]1?^ X_QHN/0R?$%GH-UX=EM]7D;[!YB,6C9B5<,"I!&2"&P?:N;M=!\
M$G>MO?7H-K:",R9=?)@56*?-MP%VEMN>HSC.*[.ZTE[ZS:TNIXY(&Y*>3@'\
MB*H)X7T^-7\NVM@'7:RF$E67LI!;! [#H!D# - C%M-$\#VOFW%OJ_E2961)
M)+WF#:N05#\ 8YY!%:4?A'1I+'RFFN+A68O%,TBED#8)VD#!' ZYQVQ4DG@W
M195G633[%EG&V13;<,,@],\<@=/0>E:\5G=0Q)##=1QQHH556$ *!P .: ,:
MS\+V.BF2XL9K@ 0K#L=PR[%!"+TS\H9L'.3GG/%1>+/^/'1/^P];?^CS70O:
MWDB%)+X$'J!$ 2/SKGO%O_'AHG_8>MO_ $>: //?V?/^2#Z%_P!=[[_TMGHH
M_9\_Y(/H7_7>^_\ 2V>B@#G_ !5_R=CXE_[)U/\ ^C37T%H7_(M:7_UZ1?\
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MHHH **** "BBB@ JK-_R$K;_ '7_ *5:JK-_R$K;_=?^E 'F7A__ )&?P_\
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MA^V_]'&NRKC?%_\ QXZ#_P!A^V_]'&@#S[]GS_D@^A?]=[[_ -+9Z*/V?/\
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M_P#B:6X%JBJOV>3_ )_)_P#QW_XFJ]I%-;R/%)=R7/5PTH7(RQXX X P/PH
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M.3_5/_NFJ^E_\@6Q_P"N$?\ Z"*YNWTWQ)#JVH33:M_HDIE:#<WF&,$@A=F
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MQ:Q1BJ O&,C+]CN!MQR5&#GTYIRWC,#_ *)<#!(Y4?XT!8N456^TM_SZS?\
M?(_QJ*:],:;OL=PW(&%4$\G'K0,OT444$A1110 4444 %%%% !56;_D)6W^Z
M_P#2K559O^0E;?[K_P!* /,] _Y&O0/^PIKG_HTUZM7E.@?\C7H'_84US_T:
M:]6H *XOPK/?MK6NVEU-<7$-O,%CEEDW#JP( _AZ>IXQTKM*X3PG W_"3>)K
MSS&\N\N$E@5U*,T>"-^,8*DYVMDD@=N* .[J"Z_X\Y_^N;?RJ>N3L/#]YI<5
M_)<ZU<7QFC;YW&'^\S<\D<9P, =3[8 .HA_U$?\ NC^525'#_J(_]T?RJ2@
MHHHH **** "BBB@ HHHH @DSNCZ_>[#/8]:GJ"3_ %D7^]ZX['\ZGH ****
M"HI88IT*2QK(OHPR*EHH SCI.GE(5-E#M@(,8V#Y"!@8J)=-L(%NE@LXTWY=
MML8 +$=?<UJU"G^L?\._].U [ON5[>]MEM80TR@A%R#UZ4]=2LF=D6Z0LOWA
MGI5O%&* T*RWMJTHB6X0N>@SUJS4%Q_JU_ZZ)_Z$*GH&+11FB@D**** "BBB
M@ HHHH **** "N.\6_\ 'AHG_8>MO_1YKL:X[Q;_ ,>&B?\ 8>MO_1YH \]_
M9\_Y(/H7_7>^_P#2V>BC]GS_ )(/H7_7>^_]+9Z* .?\5?\ )V/B7_LG4_\
MZ--?06@_\BUI?_7I%_Z *^??%7_)V/B7_LG4_P#Z--?06@_\BUI?_7I%_P"@
M"@#1HHHH **** .5AUVZN-;O]/\ [/W);APK@L/,QCGD!<<X//4>G-;NE?\
M(%L>W^CQ_P#H(JS)_J7_ -T_RJOI?_(%L?\ KA'_ .@B@"Y1110 4444 %%%
M% !1110 E0-_Q\Q_=SM;KU[=*GJNW^O3[V-K?3MU_P ^M!19HHHH)#%&***
M#%%%% $$&/*&-I&3]T8'6I\5%#_JQG=G)^]UZU+0 4444 &*,444 %%%% !1
M110 4444 %%%% !56;_D)6W^Z_\ 2K559O\ D)6W^Z_]* /,] _Y&O0/^PIK
MG_HTUZM7E.@?\C7H'_84US_T::]6H *RK+3;+3VEDM(?),IRY7//H.>@&3@=
M!DUJT4 %8/\ ;NEWD5]##<%7@1A()$:/:>1CY@.<_P QZUO5BKI6FZ?'>36=
MG'#)+&WF,O5NIY_/_.* -:'_ %$?^Z/Y5)4</^HC_P!T?RJ2@ HHHH ****
M"BBB@ HHHH AD_UD7/\ %Z9['\JFJ"3[T>,_>YP<=CUJ>@ HHHH **** "H(
M_P#6R<CMV_KWJ>H5SYK\-CC&3Q^% $U%%% %::/S$VAMIR""!G!!S59K2^-R
MLBZDZQC[T?E)AOQQFM&B@HHQV]VJX;4'<Y//EJ._TI_V>Z_Y_6_[X7_"K=%
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M6*3'SD#AMR,JJ5ZC<1C/(/TYI=-OK9=+M(BSET@CW!8V;&4!Z@>E &S15/\
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M1^4]O<1 _=C."&.>'C4X]5% 'H7G19QYBYYXW#M4_:O//[%TP7\U\NLW23S
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M:*ZH\DT,A;+;ANW,=P'H<YQ]: *\UCXR%]=WUKXFTM52,*V^0[43S-\>[Y<
ME2PS_M \X%=]:+<)9P+</YDP10[]=S8Y/0?R%<7#I^F1Z9<V,%^ LK*RN3;%
MD8'.>OS<G@'[O &,5&=)AAL&M[/Q%=1'RPFY[J)MV!U;YNYYXQW'>@#N&FAC
ME6%I460@L%+ $@=3CT%0?;+=KA=MQ$0H8-B4<< \CZ<^P^M<VEMIBRV<DUTM
MQ]F@:W(EF@;S58$'))ST)XS@\>E4_P"Q_#YD\J=X9XWA:$)));X6/RQ'M'/3
M&"?4@>E '<6?^KE_Z[/_ .A5;K$T_4+".W*R7ULAWL0#,A.,\9P:O?VKI?\
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MBVXC:0M@AO7&>G44VSO/&$*W\DUN;AHX"UE%.88Q,1T$C*?E<G(X^7&#US0
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M9\_Y(/H7_7>^_P#2V>BC]GS_ )(/H7_7>^_]+9Z* ,#Q5_R=EXG_ .R=3_\
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M+_L-6?\ Z,H \W_9\_Y(/H7_ %WOO_2V>BC]GS_D@^A?]=[[_P!+9Z* .?\
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MF=J_09/%07'@OPK=M*USH-C*\LAF<M",LYQEC[G:,^N*T6U2U37(]'9F%U)
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MJI;VMO:6ZPVL*0Q+G:D:[0,G/05;K/T^6\FL8Y+^)8KC+!U3..&(&,\\C!H
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M)?\ HOFJ_P#@3)_\;H_X65\)?^B^:K_X$R?_ !N@#N- _P"1KT#_ +"FN?\
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M89EVML.#CTKY_P#^%D_"7_HONJ_^!,G_ ,;H_P"%D_"7_HOFJ_\ @3)_\;H
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MRY5I&DRYR<G^@&!^%>"?\+)^$O\ T7W5?_ F3_XW1_PLGX2_]%\U7_P)D_\
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M+8O_ (FBB@ _X4[\*/\ HG'AS_P6Q?\ Q-'_  IWX4?]$X\.?^"V+_XFBB@
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M]$X\.?\ @MB_^)HHH /^%._"C_HG'AS_ ,%L7_Q-'_"G?A1_T3CPY_X+8O\
IXFBB@#H]+\-^']$TV/2](T2QLK* MY<$,"JB98L<#'J2?QHHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46020131047712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 16, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CEL-SCI CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000725363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 16,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-0916344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">8229 Boone Blvd<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">#802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Vienna<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">VA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">22182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">506-9460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "HC3!9Y<41X#,$  #@$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V877/B-A2&_XK&.].K)K8$X2,%9HB7M,PF@0DT.VVG%\(6H(DMN;((R;_O
MD2$VW9ICN,"6K?/R2$=Z)3'8:_.:;X6PY#U-5#[TMM9FM[Z?1UN1\OQ:9T+!
MF[4V*;=0-!L_SXS@<1&4)CX+@HZ?<JF\T:!X-C>C@=[91"HQ-R3?I2DW'W<B
MT?NA1[W/!\]RL[7N@3\:9'PC%L+^GLT-E/Q2)9:I4+G4BABQ'GIC>GO';EQ
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "HC3!9JL0B%C,!   B @  #P
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M2P$"% ,4    " "HC3!9/.4*T>\    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "HC3!9F5R<(Q &  "<)P
M$P              @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( *B-,%GEQ1'@,P0  . 0   8              " @0X(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "HC3!9GZ ;\+$"  #B#
M#0              @ %W#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *B-
M,%F7BKL<P    !,"   +              "  5,/  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( *B-,%FJQ"(6,P$  "("   /              "  3P0  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "HC3!9)!Z;HJT   #X 0  &@
M            @ &<$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " "HC3!999!YDAD!  #/ P  $P              @ &!$@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #+$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="cvm_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvm.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cvm-20240916.xsd</File>
    <File>cvm-20240916_cal.xml</File>
    <File>cvm-20240916_def.xml</File>
    <File>cvm-20240916_lab.xml</File>
    <File>cvm-20240916_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="cvm_8k.htm">cvm_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cvm_8k.htm": {
   "nsprefix": "cvm",
   "nsuri": "http://cvm.com/20240916",
   "dts": {
    "schema": {
     "local": [
      "cvm-20240916.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "cvm-20240916_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvm-20240916_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cvm-20240916_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvm-20240916_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "cvm_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://cvm.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-09-16to2024-09-16",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cvm_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-09-16to2024-09-16",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cvm_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cvm.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001654954-24-011975-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-24-011975-xbrl.zip
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M//;L%^6@_=(%#Q=S<WJU'#>_ 5!+ P04    " "HC3!9%*#169$"  !!"
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MV#(-3^S ILT^Z5;UN-'+QT)V_O%8Z!L7?K/_B"7@KN=&L^)KFQ]#,!KF090
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MS+Z6\Q\V*1;Q\TR9:K%8,>F!DV$;T>98>WC[B^9.NQOMF<>4)>B.Q$Y&XE]
M#?"(0K(LP]>_1?HV0Z05C.MY8#,+"$?60Z@#YDKM??#NN%':UVO*X;\8T_S4
MJG6_M _]J9K#N6W+2I<]VXH2B]_;B)-/?T5<)K[;;OG4]YNR5FX$[J]#HU#[
MU#Q,8C,DTV,Z4($"$=]8[[$A]?J8#,..M,^<5("H@$4^M-'=T4@-A03-<;^+
M#"U^'F/ILL.FCUI\AV[R01Q.<$_P:L"'C)UYK0,T*7IL_,K$VN<DCNN2[+B6
MQ1-[ECMP6)!LO!]DWWT7MRRA?_;*#%B'.7FPMQ8<<LJ/;8P?IZ5#!*0OSJ<9
MFN2.*LD=3LD=_!FRX(V"Q(&CV1<:GCZ8]OJ:F+ QF]J/V>/,[I;A_YC:%V>C
MPWPN)/F-.XQ@4*V_?HL^\6W XF1O^'I3_4;/E?^(X)^,0?/'R[B82<_XS?'J
M_P!02P,$%     @ J(TP66*1CQ_%$P  F%    P   !C=FU?97@Y.2YH=&WM
M7/M3V\B6_E?ZDIH,W+(=VT (CV2+ $G8&T(J9B9W=FMKJRVU[0Z26E<MV?'\
M]?N=?NAA"Y*9 +<FF_D!@BVI3Y\^YSO?>6B.9GD<O3B:"1Z^.,IE'HD7P3S^
M7_%Y?[^'KXZ>V,^._M;MGJJ@B$62LR 3/!<A*[1,INSL]/7QAPNN<Y%UNR^.
MGMA'C56X9#I?1N+YQM79/Z^ZQV_/7[\[8)\*G<O)\I"]NGQW=< &_31GN8R%
M9HE8L$S%/-EX<93Z6^FJ[NC\O\[LI?:V[JOCB_.WOQVLWGC(+HX_O#['*OWT
M\R'+Q>>\RR,Y30[\JALO'B=CG1ZRHR?I"W;GRV1R.LNQR)'.,Y5,7YS]\\WY
MR_,KMK]_],1]9!?.^3@2?O&QRD+H3J<\@#X/^H<3E>1=+7\7!T:8V@*1F.2'
M"QGF,WS5_VF#!2**4AZ&N/'Y1G^#'IWYY\X$B7,PV$T_FR]"_\7+RP^G9Q^Z
M+R^OKBXO#MBCOOF/#=+/3*M(AFZ%G=V?#C?J6EJ1R_PYX;&,E@>K*HIY-I7)
M09^6/I+QE.DL>+[A+6N 3W9[G]+IAM$'C"S\,P(.^G<CH+6);Y'D6U15.]X
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M%@  $               @ $     8W9M+3(P,C0P.3$V+GAS9%!+ 0(4 Q0
M   ( *B-,%G &P:6W $  (@#   4              "  ;,$  !C=FTM,C R
M-# Y,39?8V%L+GAM;%!+ 0(4 Q0    ( *B-,%D4H-%9D0(  $$(   4
M          "  <$&  !C=FTM,C R-# Y,39?9&5F+GAM;%!+ 0(4 Q0    (
M *B-,%F4!:8;'@8  *,Y   4              "  80)  !C=FTM,C R-# Y
M,39?;&%B+GAM;%!+ 0(4 Q0    ( *B-,%D):V.>DP0  '$D   4
M      "  =0/  !C=FTM,C R-# Y,39?<')E+GAM;%!+ 0(4 Q0    ( *B-
M,%FE>VE7\ X  )AA   *              "  9D4  !C=FU?.&LN:'1M4$L!
M A0#%     @ J(TP66*1CQ_%$P  F%    P              ( !L2,  &-V
@;5]E>#DY+FAT;5!+!08     !P ' +@!  "@-P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>cvm_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvm-20240916.xsd" xlink:type="simple"/>
    <context id="From2024-09-16to2024-09-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000725363</identifier>
        </entity>
        <period>
            <startDate>2024-09-16</startDate>
            <endDate>2024-09-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2024-09-16to2024-09-16" id="ixv-282">0000725363</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2024-09-16to2024-09-16" id="ixv-283">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2024-09-16to2024-09-16" id="ixv-303">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2024-09-16to2024-09-16" id="ixv-304">2024-09-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2024-09-16to2024-09-16" id="ixv-305">CEL-SCI CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-09-16to2024-09-16" id="ixv-306">CO</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2024-09-16to2024-09-16" id="ixv-307">001-11889</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-09-16to2024-09-16" id="ixv-308">84-0916344</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-09-16to2024-09-16" id="ixv-309">8229 Boone Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-09-16to2024-09-16" id="ixv-310">#802</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-09-16to2024-09-16" id="ixv-311">Vienna</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-09-16to2024-09-16" id="ixv-312">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-09-16to2024-09-16" id="ixv-313">22182</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-09-16to2024-09-16" id="ixv-314">703</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-09-16to2024-09-16" id="ixv-315">506-9460</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2024-09-16to2024-09-16" id="ixv-316">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2024-09-16to2024-09-16" id="ixv-317">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2024-09-16to2024-09-16" id="ixv-318">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2024-09-16to2024-09-16" id="ixv-319">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2024-09-16to2024-09-16" id="ixv-320">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-09-16to2024-09-16" id="ixv-321">CVM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-09-16to2024-09-16" id="ixv-322">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-09-16to2024-09-16" id="ixv-323">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
